TABLE 3.

Expression of OCLN splicing forms in human tissues relative to liver tissue

TissueExpression level (fold)a
WT-OCLNOCLN-ex4delOCLN-ex3 delOCLN-ex3-4delOCLN-ex3partdelOCLN-ex7ext
Thyroid tumor11.6717.142.883.984.2019.38
Lung3.8910.461.185.191.8440.70
Lung tumor3.186.921.671.91ND2.08
Colon tumor2.992.141.500.48ND1.75
Kidney2.311.111.171.302.0625.42
Ovary tumor2.151.90NDND3.378.37
Colon2.099.510.772.180.980.73
Breast tumor1.992.180.801.25ND1.50
Pancreas1.6522.77ND13.033.497.88
Brain1.501.051.60NDND17.38
Stomach1.192.220.580.850.611.71
Liver1.001.001.001.001.001.00
Small intestine0.531.610.310.83ND0.72
Bladder0.450.180.41NDND1.56
Prostate0.430.270.51ND0.575.02
Kidney tumor0.410.900.350.58ND0.78
Heart0.200.390.210.280.382.58
Breast0.130.14NDNDNDND
Muscle0.13NDNDND2.81ND
Adrenal0.08NDNDNDNDND
Spleen0.02NDND0.07ND0.41
BloodNDNDNDNDNDND
MonocytesNDNDNDNDNDND
DNA (10 ng)NDNDNDNDNDND
RNA pool (no RT)NDNDNDNDNDND
  • a ND, expression is not detected. The B2M-normalized expression level is compared to the expression level in liver (in boldface).